Phase 1/2 study initiated for ATX-559, a first-in-class inhibitor of DHX9, focused on patients with BRCA1/2-deficient breast cancer and MSI-H and/or dMMR solid tumors LEXINGTON, Mass., Dec.
Cañon Drive it's never to be found written "Cañón", and José is often written as Jose, with no accent. In an attempt to change that, Latino assemblyman Jose Medina recently introduced a bill aiming to ...